Li - Lithium
RxNorm 6448
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 6448 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Li - Lithium.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SYPrescribable
Synonym (SY):
Li - Lithium
(Atom ID: 1847108)
INPrescribable
Ingredient (IN):
Lithium
(Atom ID: 12252746)
PTPrescribable
Designated preferred name (PT):
Lithium
(Atom ID: 1847092)
FNPrescribable
Full form of descriptor (FN):
Lithium (substance)
(Atom ID: 1847111)
PTPrescribable
Designated preferred name (PT):
Lithium-containing product
(Atom ID: 10806173)
FNPrescribable
Full form of descriptor (FN):
Product containing lithium (medicinal product)
(Atom ID: 10811577)
Patient Education
Lithium
Lithium is used to treat and prevent episodes of mania (frenzied, abnormally excited mood) in people with bipolar disorder (manic-depressive disorder; a disease that causes episodes of depression, episodes of mania, and other abnormal moods). Lithium is in a class of medications called antimanic agents. It works by decreasing abnormal activity in the brain.
[Learn More]
* Please review the disclaimer below.